Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium

2021161 citationsJournal Articlehybrid Open Access

Authors

J. Beyer · University of Bern

Laurence Collette · European Organisation for Research and Treatment of Cancer

Nicolas Sauvé · European Organisation for Research and Treatment of Cancer

Gedske Daugaard · Copenhagen University Hospital

Darren R. Feldman · Memorial Sloan Kettering Cancer Center

Torgrim Tandstad · Norwegian University of Science and Technology

A. Tryakin

Abstract

PFS and OS in metastatic seminoma significantly improved in our modern series compared with the original data. The original IGCCCG classification retains its relevance, but can be further refined by adding LDH at a cutoff of 2.5× upper limit of normal as an additional adverse prognostic factor.

Topics & Keywords

Testicular diseases and treatments Neuroblastoma Research and Treatments Urologic and reproductive health conditions

UN Sustainable Development Goals

Partnerships for the goals

Publication Details

Published in: Journal of Clinical Oncology

Volume 39, Issue 14, pp. 1553-1562

DOI: 10.1200/jco.20.03292

Field-Weighted Citation Impact: 24.92